Neuphoria Therapeutics (NEUP) Assets (2020 - 2026)
Neuphoria Therapeutics (NEUP) recorded Assets of $28.71 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 0.4% from $28.59 million a year earlier but down 17.5% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Assets (2020 - 2026) Analysis & Trends
Starting with fiscal Q4 2020, Neuphoria Therapeutics' Assets history includes 13 quarters.
- Annual Assets has a five-year compound annual growth rate of -7.2% (FY2021 to FY2026).
- Across earlier fiscal years, Assets came in at $28.59 million in FY2025 (+3.4%), $27.65 million in FY2024 (-3.2%), $28.56 million in FY2023 (-38.9%) and $46.78 million in FY2022 (+12.0%).
- Quarterly Assets has ranged from $18.17 million in fiscal Q2 2025 to $46.78 million in fiscal Q4 2022 over the past five years.
- On a year-over-year basis, Assets has increased for five consecutive quarters, with growth averaging 27.6% over the last five quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 101.4% in fiscal Q2 2026, against a decline of 38.6% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $34.81 million (Q3 2026), $36.6 million (Q2 2026) and $27.34 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Neuphoria Therapeutics | 443.79 Mn | 368.60 Mn | - | 28.71 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.71 Mn |
| Mar 31, 2026 | 34.81 Mn |
| Dec 31, 2025 | 36.60 Mn |
| Sep 30, 2025 | 27.34 Mn |
| Jun 30, 2025 | 28.59 Mn |
| Mar 31, 2025 | 30.71 Mn |
| Dec 31, 2024 | 18.17 Mn |
| Sep 30, 2024 | 22.92 Mn |
| Jun 30, 2024 | 27.65 Mn |
| Jun 30, 2023 | 28.74 Mn |
| Jun 30, 2022 | 46.78 Mn |
| Jun 30, 2021 | 41.79 Mn |
| Jun 30, 2020 | 715,830.75 |
API Access
Neuphoria Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();